1. Home
  2. STRA vs BLTE Comparison

STRA vs BLTE Comparison

Compare STRA & BLTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STRA
  • BLTE
  • Stock Information
  • Founded
  • STRA 2017
  • BLTE 2018
  • Country
  • STRA United States
  • BLTE United States
  • Employees
  • STRA N/A
  • BLTE N/A
  • Industry
  • STRA Other Consumer Services
  • BLTE Biotechnology: Pharmaceutical Preparations
  • Sector
  • STRA Real Estate
  • BLTE Health Care
  • Exchange
  • STRA Nasdaq
  • BLTE Nasdaq
  • Market Cap
  • STRA 2.1B
  • BLTE 2.1B
  • IPO Year
  • STRA 1996
  • BLTE 2022
  • Fundamental
  • Price
  • STRA $78.24
  • BLTE $67.80
  • Analyst Decision
  • STRA Strong Buy
  • BLTE Strong Buy
  • Analyst Count
  • STRA 3
  • BLTE 4
  • Target Price
  • STRA $104.33
  • BLTE $96.67
  • AVG Volume (30 Days)
  • STRA 195.5K
  • BLTE 45.0K
  • Earning Date
  • STRA 07-30-2025
  • BLTE 08-11-2025
  • Dividend Yield
  • STRA 3.09%
  • BLTE N/A
  • EPS Growth
  • STRA N/A
  • BLTE N/A
  • EPS
  • STRA 4.81
  • BLTE N/A
  • Revenue
  • STRA $1,242,475,000.00
  • BLTE N/A
  • Revenue This Year
  • STRA $6.07
  • BLTE N/A
  • Revenue Next Year
  • STRA $5.02
  • BLTE N/A
  • P/E Ratio
  • STRA $16.17
  • BLTE N/A
  • Revenue Growth
  • STRA 4.31
  • BLTE N/A
  • 52 Week Low
  • STRA $72.25
  • BLTE $43.70
  • 52 Week High
  • STRA $104.51
  • BLTE $86.53
  • Technical
  • Relative Strength Index (RSI)
  • STRA 47.47
  • BLTE 57.75
  • Support Level
  • STRA $77.32
  • BLTE $68.99
  • Resistance Level
  • STRA $79.47
  • BLTE $74.49
  • Average True Range (ATR)
  • STRA 2.31
  • BLTE 3.38
  • MACD
  • STRA 0.51
  • BLTE 0.25
  • Stochastic Oscillator
  • STRA 71.56
  • BLTE 55.76

About STRA Strategic Education Inc.

Strategic Education Inc. is an education services company that provides access to high-quality education through campus-based and online post-secondary education offerings, as well as through programs to develop job-ready skills for high-demand markets. The company operates through wholly-owned subsidiaries Strayer University and Capella University, both accredited post-secondary institutions of higher education located in the United States, as well as Torrens University, an accredited post-secondary institution of higher education located in Australia. It provide employees with access to affordable and industry relevant training, certificate, and degree programs. The reportable segments of the company are U.S. Higher Education, Australia/New Zealand and Education Technology Services.

About BLTE Belite Bio Inc

Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.

Share on Social Networks: